Ligion (Tadalafil)

Tadalafil blocks the phosphodiesterase type 5 enzyme, preventing the breakdown of cyclic guanosine monophosphate (cGMP). Higher cGMP levels cause smooth‑muscle relaxation and vasodilation, which enhances blood flow to the penis, prostate, and pulmonary arteries.

The specific dose of Ligion is determined by a qualified prescriber based on the patient’s condition, response, and any concomitant medications. Physicians tailor the regimen to achieve the desired therapeutic effect while minimizing risk.

Tadalafil is not recommended for use in pregnancy or while breastfeeding because safety data are lacking. Women who are pregnant, planning to become pregnant, or nursing should avoid the medication unless a doctor determines that the benefit outweighs potential risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Ligion (tadalafil) has a longer half‑life than sildenafil or vardenafil, allowing for once‑daily dosing for BPH or a longer therapeutic window for erectile dysfunction. The choice between agents depends on patient preference, dosing schedule, and individual response.

Ligion should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Ligion is taken orally with water. It can be taken with or without food, but a consistent routine helps maintain predictable absorption. Patients should follow the dosing schedule prescribed by their healthcare provider.

Serious risks include sudden vision loss (non‑arteritic anterior ischemic optic neuropathy), prolonged erection lasting more than four hours (priapism), and severe hypotension, especially when combined with nitrates. Immediate medical attention is required if any of these events occur.

Ligion should not be used by individuals taking nitrates, those with severe uncontrolled hypertension, recent heart attack or stroke, or patients with known hypersensitivity to tadalafil or any of the tablet’s excipients. A healthcare professional should evaluate suitability before prescribing.